Sanyal, A. J., Newsome, P. N., Kliers, I., Østergaard, L. H., Long, M. T., Kjær, M. S., Cali, A. M., Bugianesi, E., Rinella, M. E., Roden, M., Ratziu, V. (2025). Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2413258